Peregrine Ventures

Tel Aviv, Israel
cb
At Peregrine, we are dedicated to supporting and advancing medical innovation through strategic investments. The Peregrine advantage brings together deep industry knowledge and an embedded synergetic strategy. This allows our team of investment professionals to support our portfolio companies in the development of meaningful breakthroughs in healthcare. Whether at an early-stage seed or advanced growth stage, Peregrine’s synergetic approach to investing reaches beyond capital. This allows our firm to provide expert, focused, and concrete services throughout the company lifecycle.
Founded:2001
Firm Location:Tel Aviv, Israel • Israel • Or Yehuda, Israel
Investor Firms That Co-Invest with Peregrine Ventures
OurCrowd
Peregrine Ventures Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Tal Carasso, Venture Partner at Peregrine Ventures
Tal Carasso
Peregrine Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Photo of David Eldar, Venture Partner at Peregrine Ventures
David Eldar
Peregrine Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Or Yehuda (Israel)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+11
Photo of Eyal Lifschitz, Managing Partner at Peregrine Ventures
Eyal Lifschitz
Peregrine Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Seed)
+8
Photo of Boaz Lifschitz, General Partner at Peregrine Ventures
Boaz Lifschitz
Peregrine Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Tel Aviv (Israel)
Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Israel (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in SaaS (Series B), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in SaaS (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in SaaS (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in SaaS (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in SaaS (Seed)
+37
Photo of Lior Shahory, General Partner at Peregrine Ventures
Lior Shahory
Peregrine Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Seed)
+4
Photo of Tamir Tal, Venture Partner at Peregrine Ventures
Tamir Tal
Peregrine Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Or Yehuda (Israel)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+11
Photo of Shiran Tehila Mashiah, Analyst at Peregrine Ventures
Shiran Tehila Mashiah
Peregrine Ventures
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+11